Skip to content
★ Sign in to follow
SL

Steven L. Krill

Eagle Pharmaceuticals, Inc.
Total declarations
41
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (19 ops.)
€6.6M

Latest filing published 09 Jan 2018 for Eagle Pharmaceuticals, INC..

Filing timeline

BuySale
Steven L. Krill

Insider track record

Disclosed buys
0
Disclosed sells
19
Signal history

Steven L. Krill: trading record in brief

This profile gathers the share dealings of Steven L. Krill in Eagle Pharmaceuticals, Inc. Between 16 June 2015 and 7 January 2018, the trades on record add up to 41 filings.

No open-market purchase appears, only 19 sales worth €6.6M. Besides market trades, the filings include 1 share grant and 21 option exercises.

The record was last updated on 9 January 2018 with a share grant in Eagle Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Steven L. Krill

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations41 total

25 of 41 declarations